Notre Dame law professor Jimmy Gurulé, a terrorist financing expert, testified Thursday, June 23, before the Congressional Task Force to Investigate Terrorism Financing—part of the House Committee on Financial Services.
Each year, an estimated 48 million Americans get sick—sometimes mortally—from an all-too common source: foodborne pathogens. Even as the industry looks for ways to curb outbreaks, a new Notre Dame study finds that just being able to trace a product through its supply chain is at once critical, and difficult.
Timothy Beers, the Notre Dame Chair in Astrophysics, is part of a team that has used the Cosmic Origins Spectrograph on the Hubble Space Telescope to study key regions of the ultraviolet spectrum of a star thought to have been enriched by elements from one of the first generation of stars.
A research team led by Notre Dame chemist Brian Baker is developing a new immunotherapy, a treatment that enhances immune system function in order to treat or prevent disease, as a means to more effectively target and kill cancer cells. According to Baker, “Immunotherapy is changing how cancer is treated.”
Nearly two years ago, Notre Dame announced a plan to build a $36 million turbomachinery research and testing laboratory at Ignition Park in South Bend. On Tuesday, June 7, the 25,000-square-foot facility was officially opened with a ribbon cutting ceremony.
Decades of unregulated industrial waste dumping in areas of the Great Lakes have created a host of environmental and wildlife problems. Now it appears that Lake Michigan painted and snapping turtles could be a useful source for measuring the resulting pollution.
Notre Dame medical entomologist Nicole L. Achee is a member of a committee convened to summarize the scientific discoveries related to gene drives and considerations for their responsible use. The National Institutes of Health and the Foundation for the National Institutes of Health asked the National Academies of Sciences, Engineering and Medicine to convene the committee.
Drugs to treat cancer and Alzheimer’s disease usually target the active sites of specific protein molecules sustaining the disease. Traditional drug design views proteins as rigid 3-D objects with active sites consisting of surface-accessible “pockets” with a specific, well-defined structure and involves finding small molecules with shapes that fit specifically into this pocket. A new study from Notre Dame researchers suggests that there are alternative approaches to targeting these proteins, a significant finding for future clinical applications.
George A. Lopez, the Rev. Theodore M. Hesburgh, C.S.C., Professor Emeritus of Peace Studies at Notre Dame’s Kroc Institute for International Peace Studies, will serve as an evaluating judge for a new competition launched June 2 that will award a $100 million grant to a single proposal designed to help solve a critical problem affecting people, places or the planet. The John D. and Catherine T. MacArthur Foundation’s competition, called 100&Change, is open to organizations working in any field of endeavor anywhere.
Growing urbanization increases the overall temperature of a city as buildings, roads, parking lots and other infrastructure absorb heat, creating an urban heat island (UHI). A UHI causes areas like Chicago to be significantly warmer than surrounding rural areas. Newly published Notre Dame research found that the use of roofs with vegetation or reflective surfaces on top of Chicago’s current infrastructure could reduce UHI by lowering roof temperatures by a range of 3 to 4 degrees Celsius (5.4 to 7.2 degrees Fahrenheit).